Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4c41d12db7cda61b70a168529bcf2316 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57449 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
filingDate |
2004-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da938767a9f91ee1b946d8a37e367c78 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ee617c5a378c63e3fcc30416a8e31a7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4edaa84e1b59ac997b742e4e7675a13 |
publicationDate |
2006-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1668149-A1 |
titleOfInvention |
Diagnostic marker for ovarian cancer |
abstract |
The present invention relates to methods of detecting, monitoring the efficacy of treatment of, and assessing the severity of ovarian cancer, by assessing the concentration of haptoglobin-1 precursor in a sample of biological fluid. The invention also relates to a kit comprising an antibody or nucleic acid probe specific for haptoglobin-1 precursor for use in the diagnosis of ovarian cancer, monitoring the efficacy of treatment of ovarian cancer, or assessing the severity of ovarian cancer. |
priorityDate |
2003-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |